The North America Meningitis Imaging Market would witness market growth of 4.2% CAGR during the forecast period (2021-2027).
The doctor must diagnose the chances of aetiology and rationally select some additional diagnostic tests based on a variety of factors such as patient history and symptomatology, regional epidemiology, and basic cerebrospinal fluid testing (protein, etc.) at the time of diagnosing meningitis.
Various developments in technology are improving the delivery of more speedy and accurate results. The Immuno-Mycologics cryptococcal antigen lateral flow assay has revolutionized cryptococcal diagnosis, and automated nucleic acid amplification techniques, which improved the bacterial and mycobacterial meningitis diagnosis.
According to the United Nations Programme on HIV/AIDS (UNAIDS), 24.5 million HIV-positive persons worldwide received antiretroviral medication in 2019. Additionally, greater government intervention in controlling meningitis outbreaks and an increase in demand for immediate diagnosis systems would create more demand for meningitis imaging. Between 2015 and 2019, there was an almost 30% increase in these reportable STDs.
The US market dominated the North America Meningitis Imaging Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $70.7 Thousands by 2027. The Canada market is experiencing a CAGR of 6.6% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 5.6% during (2021 - 2027).
Based on Product Type, the market is segmented into Computer Tomography (CT), Magnetic Resonance Imaging (MRI) and Positron Emission Tomography. Based on Disease Type, the market is segmented into Viral Meningitis, Fungal Meningitis, Bacterial Meningitis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Diagnostic Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Meningitis Imaging Market is Estimated to reach $223.7 Thousands by 2027, at a CAGR of 4.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shimadzu Corporation, Accuray, Incorporated, United Imaging Healthcare Co., Ltd., Positron Corporation, Neusoft Medical Systems Co., Ltd. (Neusoft Corporation), Siemens AG (Siemens Healthineers), Fujifilm Holdings Corporation, General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., and Canon, Inc. (Canon Medical Systems Corporation).
By Product Type
By Disease Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 